Guidance

Calderdale, Kirklees and Wakefield: bowel cancer screening

Executive summary of the quality assurance (QA) visit to the Calderdale, Kirklees and Wakefield NHS bowel cancer screening programme on 27 and 28 November 2019.

• From: Public Health England
• Published: 7 August 2020

Documents

QA report: bowel cancer screening, Calderdale, Kirklees and Wakefield

Ref: PHE publications gateway number: GW-1461

PDF, 258 KB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Quality assurance (QA) visits are carried out by the Public Health England screening quality assurance service (SQAS).

The evidence for this report comes from:

• routine monitoring data collected by the NHS screening programmes
• data and reports from external organisations as appropriate
• evidence submitted by the provider(s), commissioner and external organisations
• information collected during pre-review visits to the screening centre office at Calderdale Royal Hospital (CRH), the pathology departments at CRH and Dewsbury and District Hospital (DDH), and the radiology walkthroughs at Pinderfields General Hospital (PGH) and Huddersfield Royal Infirmary on 13, 27 and 28 November
• information shared with the North regional SQAS as part of the visit process

Published 7 August 2020